Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 109

1.

Metabolic Stability of D-Allulose in Biorelevant Media and Hepatocytes: Comparison with Fructose and Erythritol.

Maeng HJ, Yoon JH, Chun KH, Kim ST, Jang DJ, Park JE, Kim YH, Kim SB, Kim YC.

Foods. 2019 Oct 1;8(10). pii: E448. doi: 10.3390/foods8100448.

2.

Preparation of Ondansetron Hydrochloride-Loaded Nanostructured Lipid Carriers Using Solvent Injection Method for Enhancement of Pharmacokinetic Properties.

Duong VA, Nguyen TT, Maeng HJ, Chi SC.

Pharm Res. 2019 Jul 26;36(10):138. doi: 10.1007/s11095-019-2672-x.

PMID:
31350675
3.

BAM8-22 and its receptor MRGPRX1 may attribute to cholestatic pruritus.

Sanjel B, Maeng HJ, Shim WS.

Sci Rep. 2019 Jul 26;9(1):10888. doi: 10.1038/s41598-019-47267-5.

4.

Strategies for developing and optimizing cancer vaccines.

Maeng HM, Berzofsky JA.

F1000Res. 2019 May 13;8. pii: F1000 Faculty Rev-654. doi: 10.12688/f1000research.18693.1. eCollection 2019. Review.

5.

Rhododendrin-Induced RNF146 Expression via Estrogen Receptor β Activation is Cytoprotective Against 6-OHDA-Induced Oxidative Stress.

Kim H, Park J, Leem H, Cho M, Yoon JH, Maeng HJ, Lee Y.

Int J Mol Sci. 2019 Apr 10;20(7). pii: E1772. doi: 10.3390/ijms20071772.

6.

Development and Evaluation of Poorly Water-Soluble Celecoxib as Solid Dispersions Containing Nonionic Surfactants Using Fluidized-Bed Granulation.

Kwon HJ, Heo EJ, Kim YH, Kim S, Hwang YH, Byun JM, Cheon SH, Park SY, Kim DY, Cho KH, Maeng HJ, Jang DJ.

Pharmaceutics. 2019 Mar 20;11(3). pii: E136. doi: 10.3390/pharmaceutics11030136.

7.

Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and N-Acetylprocainamide with Cimetidine, an Inhibitor of rOCT2 and rMATE1, in Rats.

Jeong YS, Balla A, Chun KH, Chung SJ, Maeng HJ.

Pharmaceutics. 2019 Mar 6;11(3). pii: E108. doi: 10.3390/pharmaceutics11030108.

8.

Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report.

Monge C, Maeng H, Brofferio A, Apolo AB, Sathya B, Arai AE, Gulley JL, Bilusic M.

J Immunother Cancer. 2018 Dec 18;6(1):150. doi: 10.1186/s40425-018-0473-0.

9.

Differential regulation of intestinal and hepatic CYP3A by 1α,25-dihydroxyvitamin D3 : Effects on in vivo oral absorption and disposition of buspirone in rats.

Maeng HJ, Doan TNK, Yoon IS.

Drug Dev Res. 2019 May;80(3):333-342. doi: 10.1002/ddr.21505. Epub 2018 Dec 10.

PMID:
30537097
10.

Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream.

Kang JW, Cho HJ, Lee HJ, Jin HE, Maeng HJ.

Int J Biol Macromol. 2019 Mar 15;125:61-71. doi: 10.1016/j.ijbiomac.2018.12.028. Epub 2018 Dec 3.

PMID:
30521919
11.

Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility, In-Vitro Dissolution and Bioavailability in Rats.

Kim RM, Jang DJ, Kim YC, Yoon JH, Min KA, Maeng HJ, Cho KH.

Pharmaceutics. 2018 Nov 28;10(4). pii: E247. doi: 10.3390/pharmaceutics10040247.

12.

Preparation of Silica Microparticles as Volatile Material Carrier and Their Sustained-Release Property.

Do YS, Cho KH, Kim HC, Kwon JY, Kim ST, Park SY, Kim YH, Kim JE, Park YJ, Maeng HJ, Jang DJ.

J Nanosci Nanotechnol. 2019 Feb 1;19(2):1188-1191. doi: 10.1166/jnn.2019.15919.

PMID:
30360231
13.

Mitoxantrone-Loaded PEGylated Gold Nanocomplexes for Cancer Therapy.

Yoon JH, Cho HJ, Jin HE, Maeng HJ.

J Nanosci Nanotechnol. 2019 Feb 1;19(2):687-690. doi: 10.1166/jnn.2019.15902.

PMID:
30360142
14.

Preparation, Characterization, and In Vitro Release of Chitosan-Ecabet Electrolyte Complex for the Mucosal Delivery.

Kim JY, Kim DH, Min KA, Maeng HJ, Jang DJ, Cho KH.

J Nanosci Nanotechnol. 2019 Feb 1;19(2):640-645. doi: 10.1166/jnn.2019.15961.

PMID:
30360135
15.

Synthesis of Gemcitabine-Threonine Amide Prodrug Effective on Pancreatic Cancer Cells with Improved Pharmacokinetic Properties.

Hong S, Fang Z, Jung HY, Yoon JH, Hong SS, Maeng HJ.

Molecules. 2018 Oct 11;23(10). pii: E2608. doi: 10.3390/molecules23102608.

16.

Development and Evaluation of a Reconstitutable Dry Suspension to Improve the Dissolution and Oral Absorption of Poorly Water-Soluble Celecoxib.

Kim HI, Park SY, Park SJ, Lee J, Cho KH, Jee JP, Kim HC, Maeng HJ, Jang DJ.

Pharmaceutics. 2018 Aug 29;10(3). pii: E140. doi: 10.3390/pharmaceutics10030140.

17.

Identification of the primary determining factor(s) governing the oral absorption of edaravone in rats.

Hyung S, Jeong YS, Yeo J, Song YK, Kim MS, Im YJ, Maeng HJ, Chung SJ.

Eur J Pharm Sci. 2018 Oct 15;123:312-320. doi: 10.1016/j.ejps.2018.07.052. Epub 2018 Jul 26.

PMID:
30056192
18.

Diagnostic value of peripheral blood immune profiling in colorectal cancer.

Choi J, Maeng HG, Lee SJ, Kim YJ, Kim DW, Lee HN, Namgung JH, Oh HM, Kim TJ, Jeong JE, Park SJ, Choi YM, Kang YW, Yoon SG, Lee JK.

Ann Surg Treat Res. 2018 Jun;94(6):312-321. doi: 10.4174/astr.2018.94.6.312. Epub 2018 May 29.

19.

Application of laser-induced breakdown spectroscopy for real-time detection of contamination particles during the manufacturing process.

Lee H, Maeng H, Kim K, Kim G, Park K.

Appl Opt. 2018 Apr 20;57(12):3288-3292. doi: 10.1364/AO.57.003288.

PMID:
29714318
20.

Development of Polyethylene Glycol-Conjugated Chitosan Oligosaccharide Derivative-Stabilized Gold Nanoassemblies.

Cho HJ, Termsarasab U, Lee SY, Maeng HJ, Kim DD, Yoon IS.

J Nanosci Nanotechnol. 2017 Apr;17(4):2370-373. No abstract available.

PMID:
29641167
22.

Cancer vaccines: translation from mice to human clinical trials.

Maeng H, Terabe M, Berzofsky JA.

Curr Opin Immunol. 2018 Apr;51:111-122. doi: 10.1016/j.coi.2018.03.001. Epub 2018 Mar 16. Review.

23.

Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.

Maeng HG, Lee SJ, Lee YA, Lee HJ, Kim YJ, Lee JK, Kim JC, Choi J.

Oncol Lett. 2018 Jan;15(1):1325-1333. doi: 10.3892/ol.2017.7365. Epub 2017 Nov 8.

24.
25.

Designing Tyrosinase siRNAs by Multiple Prediction Algorithms and Evaluation of Their Anti-Melanogenic Effects.

Kwon OS, Kwon SJ, Kim JS, Lee G, Maeng HJ, Lee J, Hwang GS, Cha HJ, Chun KH.

Biomol Ther (Seoul). 2018 May 1;26(3):282-289. doi: 10.4062/biomolther.2017.115.

26.

Inter- and Intrarater Reliabilities of the Test of Gross Motor Development-Third Edition Among Experienced TGMD-2 Raters.

Maeng H, Webster EK, Pitchford EA, Ulrich DA.

Adapt Phys Activ Q. 2017 Oct 1;34(4):442-455. doi: 10.1123/apaq.2016-0026. Epub 2017 Oct 16.

PMID:
29035576
27.

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice.

Kim KM, Jin HJ, Lee SY, Maeng HJ, Lee GY, Oh TJ, Choi SH, Jang HC, Lim S.

Endocrinol Metab (Seoul). 2017 Sep;32(3):389-395. doi: 10.3803/EnM.2017.32.3.389.

28.

Simultaneous quantification of volitinib and gefitinib in rat plasma by HPLC-MS/MS for application to a pharmacokinetic study in rats.

Noh CK, Lee JH, Kim MS, Maeng HJ, Chung SJ.

J Sep Sci. 2017 Oct;40(19):3782-3791. doi: 10.1002/jssc.201700574. Epub 2017 Aug 28.

PMID:
28749011
29.

Ginsenoside improves physicochemical properties and bioavailability of curcumin-loaded nanostructured lipid carrier.

Vijayakumar A, Baskaran R, Maeng HJ, Yoo BK.

Arch Pharm Res. 2017 Jul;40(7):864-874. doi: 10.1007/s12272-017-0930-1. Epub 2017 Jul 15.

PMID:
28712035
30.

Cefdinir Solid Dispersion Composed of Hydrophilic Polymers with Enhanced Solubility, Dissolution, and Bioavailability in Rats.

Cho HJ, Jee JP, Kang JY, Shin DY, Choi HG, Maeng HJ, Cho KH.

Molecules. 2017 Feb 13;22(2). pii: E280. doi: 10.3390/molecules22020280.

31.
32.

Suppression of Nrf2 attenuates adipogenesis and decreases FGF21 expression through PPAR gamma in 3T3-L1 cells.

Kim BR, Lee GY, Yu H, Maeng HJ, Oh TJ, Kim KM, Moon JH, Lim S, Jang HC, Choi SH.

Biochem Biophys Res Commun. 2018 Mar 18;497(4):1149-1153. doi: 10.1016/j.bbrc.2017.01.107. Epub 2017 Jan 25.

PMID:
28131830
33.

Specific Inhibition of the Distribution of Lobeglitazone to the Liver by Atorvastatin in Rats: Evidence for a Rat Organic Anion Transporting Polypeptide 1B2-Mediated Interaction in Hepatic Transport.

Yim CS, Jeong YS, Lee SY, Pyeon W, Ryu HM, Lee JH, Lee KR, Maeng HJ, Chung SJ.

Drug Metab Dispos. 2017 Mar;45(3):246-259. doi: 10.1124/dmd.116.074120. Epub 2017 Jan 9.

PMID:
28069721
34.

The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE -/- mice fed a western diet.

Han JH, Oh TJ, Lee G, Maeng HJ, Lee DH, Kim KM, Choi SH, Jang HC, Lee HS, Park KS, Kim YB, Lim S.

Diabetologia. 2017 Feb;60(2):364-376. doi: 10.1007/s00125-016-4158-2. Epub 2016 Nov 19.

PMID:
27866224
35.

Pharmacokinetic study of meropenem in healthy beagle dogs receiving intermittent hemodialysis.

Byun SY, Jeong JW, Choi JH, Lee KP, Youn HY, Maeng HJ, Song KH, Koo TS, Seo KW.

J Vet Pharmacol Ther. 2016 Dec;39(6):560-565. doi: 10.1111/jvp.12326. Epub 2016 Jun 15.

PMID:
27302674
36.

Feasibility of the functional expression of the human organic anion transporting polypeptide 1B1 (OATP1B1) and its genetic variant 521T/C in the mouse liver.

Chae YJ, Lee KR, Lee JH, Lee W, Kim DD, Chung SJ, Maeng HJ.

Eur J Pharm Sci. 2017 Jan 1;96:28-36. doi: 10.1016/j.ejps.2016.09.012. Epub 2016 Sep 10.

PMID:
27619346
37.

Enhanced Cellular Uptake and Pharmacokinetic Characteristics of Doxorubicin-Valine Amide Prodrug.

Park Y, Park JH, Park S, Lee SY, Cho KH, Kim DD, Shim WS, Yoon IS, Cho HJ, Maeng HJ.

Molecules. 2016 Sep 22;21(10). pii: E1272. doi: 10.3390/molecules21101272.

38.

Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis.

Chihara D, Masarova L, Newberry KJ, Maeng H, Ravandi F, Garcia-Manero G, Ferrajoli A, Cortes J, Kantarjian H, Verstovsek S.

Leuk Res. 2016 Sep;48:1-5. doi: 10.1016/j.leukres.2016.06.007. Epub 2016 Jun 23.

39.

Quercetin Directly Interacts with Vitamin D Receptor (VDR): Structural Implication of VDR Activation by Quercetin.

Lee KY, Choi HS, Choi HS, Chung KY, Lee BJ, Maeng HJ, Seo MD.

Biomol Ther (Seoul). 2016 Mar 1;24(2):191-8. doi: 10.4062/biomolther.2015.122.

40.

Growth Mechanism of Highly Crystalline CdS Spheres with Grainy Surfaces.

Kim NW, Maeng HJ, Jeon Y, Yu H.

J Nanosci Nanotechnol. 2015 Nov;15(11):8716-20.

PMID:
26726582
41.

Development and validation of a highly sensitive LC-MS/MS method for the determination of acacetin in human plasma and its application to a protein binding study.

Kim SB, Lee T, Lee HS, Song CK, Cho HJ, Kim DD, Maeng HJ, Yoon IS.

Arch Pharm Res. 2016 Feb;39(2):213-220. doi: 10.1007/s12272-015-0697-1. Epub 2015 Dec 16.

PMID:
26677081
42.

Effects of 1α,25-Dihydroxyvitamin D3 on Intestinal Absorption and Disposition of Adefovir Dipivoxil and Its Metabolite, Adefovir, in Rats.

Yoon IS, Son JH, Kim SB, Choi MK, Maeng HJ.

Biol Pharm Bull. 2015;38(11):1732-7. doi: 10.1248/bpb.b15-00356.

43.

Vitamin D Receptor-Mediated Upregulation of CYP3A4 and MDR1 by Quercetin in Caco-2 cells.

Chae YJ, Cho KH, Yoon IS, Noh CK, Lee HJ, Park Y, Ji E, Seo MD, Maeng HJ.

Planta Med. 2016 Jan;82(1-2):121-30. doi: 10.1055/s-0035-1557898. Epub 2015 Sep 14.

PMID:
26366751
44.

The identification of lobeglitazone metabolites in rat liver microsomes and the kinetics of the in vivo formation of the major metabolite M1 in rats.

Lee JH, Ahn SH, Maeng HJ, Lee W, Kim DD, Chung SJ.

J Pharm Biomed Anal. 2015 Nov 10;115:375-82. doi: 10.1016/j.jpba.2015.07.040. Epub 2015 Jul 30.

PMID:
26275726
45.

Quantification of mequitazine in human plasma by gas chromatography- quadrupole mass spectrometry and its application to a human pharmacokinetic study.

Ahn SH, Maeng HJ.

Biomed Chromatogr. 2016 Apr;30(4):574-8. doi: 10.1002/bmc.3585. Epub 2015 Sep 20.

PMID:
26268745
46.

Facile fabrication of a cerium oxide nanorod.

Kim NW, Maeng HJ, Lee DK, Yu H.

J Nanosci Nanotechnol. 2014 Nov;14(11):8834-8.

PMID:
25958613
47.

Houttuynia cordata Extract Improves Physical Endurance Performance by Regulating Endothelial Production of Nitric Oxide.

Yang UJ, Maeng H, Park TS, Shim SM.

J Med Food. 2015 Sep;18(9):1022-31. doi: 10.1089/jmf.2014.3371. Epub 2015 Apr 29.

PMID:
25923355
48.

Reference values for peripheral blood lymphocyte subsets in a healthy korean population.

Choi J, Lee SJ, Lee YA, Maeng HG, Lee JK, Kang YW.

Immune Netw. 2014 Dec;14(6):289-95. doi: 10.4110/in.2014.14.6.289. Epub 2014 Dec 22.

49.

Recent bioanalytical methods for quantification of third-generation cephalosporins using HPLC and LC-MS(/MS) and their applications in pharmacokinetic studies.

Jin HE, Jin SE, Maeng HJ.

Biomed Chromatogr. 2014 Nov;28(11):1565-87. doi: 10.1002/bmc.3330. Epub 2014 Oct 8. Review.

PMID:
25294385
50.

Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.

Kim YC, Kim IB, Noh CK, Quach HP, Yoon IS, Chow ECY, Kim M, Jin HE, Cho KH, Chung SJ, Pang KS, Maeng HJ.

J Pharm Sci. 2014 Nov;103(11):3793-3805. doi: 10.1002/jps.24195. Epub 2014 Sep 29.

PMID:
25266751

Supplemental Content

Support Center